The Janus kinase-signal transducers and activators of transcription
INTRODUCTION
Rheumatoid arthritis (RA) is a progressive autoimmune inflammatory musculoskeletal disease 1 characterized by over production of two known antibodies -rheumatoid factor and the most sensitive, specific anti-citrullinated peptide antibody (ACPA) 2 . Pathophysiology of RA involves a complex network of inflammatory and immunity interacting pathways that finally mediate abnormal release of matrix metalloproteinases (MMPs) in synovium and promote joint damage 3 .
The janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is one of most intracellular signaling pathways that recently have confirmed to play an important role in RA pathogenesis 4 . The JAK/STAT signal transduction pathway is mainly utilized by pro-inflammatory cytokine such as interleukin-6 (IL-6) that expressed abundantly in the synovial fluid and regulate gene expression and cellular activation, proliferation, and differentiation 5 . Briefly, binding of cytokine IL-6 to its receptor activates JAKs, protein tyrosine This is an Open Access article licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/ ), which permits unrestricted Non Commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Published by Oriental Scientific Publishing Company © 2017 kinases, phosphorylation and to the recruitment, phosphorylation of STATs that subsequently dimerize and translocate to the nucleus, where they can activate transcription of the targeted genes 6 . A d j u va n t i n d u c e d a r t h r i t i s i s t h e classical and most common model for studying the pathogenesis of experimental RA in rats 7 . Previous studies have shown that subcutaneous injection of mycobacterium tuberculosis in rats can massively activate pro-inflammatory cytokines release particularly IL-6 that has a pivotal role in activation of JAK2/STAT3-induced RA and cartilage degradation 8 .
Lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria, is a potent activator of a variety of immunity and inflammatory cascades 9 . LPS has been shown to initiate multiple intracellular signaling events, activate immune system and mediate the release of diverse pro-inflammatory mediators, including IL-6 10 . Therefore, LPS may has an imperative role in occurrence of some autoimmune and inflammatory diseases 11 .
The present study, therefore, was designed to evaluate and compare possible stimulatory effect of LPS on JAK2/STAT3 signaling pathway and subsequently its prospect role in RA pathogenesis versus the classical CFA-induced arthritis.
MATERIALS AND METHODS

Animals
Adult female Wister Albino rats, weighing 180-200 g were obtained from Modern Veterinary Office for Laboratory Animals, Cairo, Egypt. Rats were adapted in plastic cages with free access to food and water for two weeks before being subjected to laboratory experiments. Rats were maintained in a room controlled at (25 ± 
Experimental design
Animals were randomly assigned into three groups; a normal control group (received vehicle only), a CFA arthritic control group and LPS group. CFA was given by subcutaneous injection (S.C.) in a dose of 0.4 ml on 1, 5 and 9 days. LPS was given by intra-peritoneal (I.P.) injection at a dose of 100µg/kg from day 1 through 12 days. Doses of CFA and LPS had been chosen based on pilot trials guided with published literature 12, 13 respectively. On day 13 serum and tissue samples were taken for assessment of serum IL-6 as a specific ligand for JAK/STAT pathway and serum ACPA as a specific rheumatoid biomarker, as well as, tissue expression of JAK2 and STAT3.
METHODS
Induction of rheumatoid arthritis
For RA induction, three separate S.C doses of CFA, each of 0.4 ml were injected in planter surface of the right hind limb, on days 1, 5 and 9. 
Serum sampling
Twenty-four hours following the last dose of CFA and LPS, animals were deeply anesthetized and blood samples were collected into non heparinized tubes from orbital venous plexus and centrifuged at 1000 xg for 30 minutes in a cooling centrifuge (Sigma 3-30k, USA). The clear serum layer was withdrawn and stored in a -80C deep freezer (Als Angelantoni Life Science, Italy) for further assessment of serum IL-6 and ACPA.
Tissue sampling
Soon after blood withdrawal, animals were scarified and the fresh whole knee joints were dissected, placed in round-bottom microcentrifuge tubes and kept on ice for immediate homogenization for western blot analysis of JAK2 and STAT3.
Assessment of serum IL-6 and ACPA biomarkers
Serum IL-6 and ACPA were assessed using ELISA reagent kits according to the methods described by kits manufacturer instructions based on the principles described earlier 15, 16 . Both ELISA assays were done using Awareness Technologies Stat Fax 2100 Microplate Reader (SKU#: 8036-10-0020).
Western blot analysis for tissue level of JAK2 and STAT3
Tissue levels of JAK2 and STAT3 were measured using the western blot technique described earlier 16, 17 . To ascertain the phosphorylation level of the various JAK and STAT proteins in synovial tissue, briefly, Each 5mg of synovial tissue was treated with 300 µl RIPA lysis buffer and homogenized with electrical homogenize and maintained on a constant agitation for 2 hr at 4°C, then the lysate was kept on ice for 30 minutes and cell debris was removed by centrifugation at ~16,000 xg for 30 minutes at 4°C. The protein concentrations were determined by Bradford assay, separated by 10% SDS-PAGE using BioRad mini protein electrophoresis separation unit (USPTO) and transferred onto a nitrocellulose membrane. After blocking with tris-buffered saline with tween 20 (TBST) buffer and 3% bovine serum albumin (BSA) at room temperature for 1 hr, the membranes were incubated overnight with primary antibodies against JAK2/STAT3, followed with appropriate horseradish peroxidase conjugated secondary antibodies. The chemiluminescent substrate (ClarityTM Western ECL substrate -BIO-RAD, USA) was applied to the blot according to the manufacturer's recommendation. The chemiluminescent signals were captured using a CCD camera-based imager. Image analysis software was used to read the band intensity of the target proteins against control sample after normalization by beta actin (B-actin) on the ChemiDoc Tm MP imaging System with Image Lab Tm Software, version 5.1 (Bio-Rad, 170-8280).
Statistical analysis
Statistical analysis were performed by one way analysis of variance (ANOVA) followed by Tukey-Kramer post hoc test, computer software program (Graph Pad Prism 6) with a value of P < 0.05 considered statistically significant. Results were expressed as means ± standard error of the mean (S.E.M). Figure 1 (A) showed that both CFA and LPS significantly activate JAK2 tissue expression if compared to normal control group. No significant difference between each other was observed. Figure 1 (B) illustrated that rats injected with CFA or LPS significantly increased expression of STAT3 in synovium tissue when compared to normal rats. No significant difference in tissue level of STAT3 had been detected between CFA-rats and LPS-rats.
RESULTS
Effect of CFA and LPS on tissue JAK2 and STAT3 expression
Effect of CFA and LPS on serum inflammatory cytokine IL-6 and ACPA
As shown in table 1, the concentration of serum cytokine IL-6 was significantly elevated in CFA group and LPS if compared with that of normal group. No significant difference has been shown between CFA and LPS groups. Moreover, both CFA group and LPS group induced an elevation in serum ACPA if compared to normal control, with non-obvious significant different between each group.
DISCUSSION
Rheumatoid arthritis is one of the complex inflammatory, immune-mediated diseases, which depend on multiple signaling and effector pathways that ultimately leads to the progressive destruction of joint structure.
Interleukin-6 is one of the key cytokines that drive immune response, particularly during inflammatory joint. Previously, it was evidenced that IL-6 use the common receptor subunit gp130 for activation of JAK2/STAT3 signaling pathway, consequently promote physiological responses and molecular mechanisms involved in RA pathogenesis.
It has been reported that endotoxemia was adjunct with inflammation as well as increase in IL-6 concentration 18 . Depending on that, the present study investigate the possible inducible role of LPS, the prototypical endotoxin, on JAK2/STAT3 signaling pathway activation in RA compared with the classical CFA-induced RA in rats.
The current study results clarified that three S.C injected doses of CFA could positively activate JAK2/STAT3 signaling pathway in synovium tissue through releasing of inflammatory cytokine IL-6, this was evidenced by significant increase in serum IL-6, tissue JAK2 and tissue STAT3 compared to normal rats. In support, adenovirus-mediated gene transfer of CIS3 could suppress bone destruction and ameliorate IL-6-gp130-JAK2/STAT3-signaling pathway induced by CFA 19 . Moreover, CFA showed an extensive joint destruction and arthritis progression, confirmed by significant elevation in serum ACPA. Similarly, it has previously reported by Ali et al. (2015) and Bonezzi et al. (2016) that CFA is one the most appropriate agents for experimental induction of RA.
It seems from our results that I.P injection of LPS to rats had a stimulatory effect on both JAK2 and STAT3. Despite other investigations had not discuss role of LPS in activation of JAK/STAT pathway in RA, many of them handled its role in other disease where Victoni et al. (2014) and Ho et al. (2017) reported that LPS can induce JAK/STAT activation in bronchial airway and prostate cells respectively. This activation of JAK2/STAT3 signaling pathway with LPS can be explained to the significant increase in serum IL-6 after LPS injection to rats, where LPS interact with host cells, such as monocytes and macrophages, and leads to the production of inflammatory mediators, including IL-6 24 .
To clarify whether this activation of JAK2 and STAT3 can play a precise role in RA development, ACPA, highly specific and sensitive marker for RA 25 , was measured. Our results viewed that LPS could trigger RA progression concomitant with harmful joint damage, evidenced by significant increase in in serum ACPA if compared to normal group. Almost no researches were conducted regarding the effect of LPS on ACPA in experimental arthritis, however Shi et al. (2014) illustrated that LPS can induce immunopathological cascades that could contributed to some autoimmune disease. Side by side, Le et al. (2013) stated that LPS can increase the formation and survival of mature osteoclasts. Our data distinct that LPS exhibited a motivated effect on each of; tissue JAK2, STAT3, serum IL-6 and serum ACPA at the same level as CFA or even little more. Putting together, these findings strongly suggest that LPS can induce RA at least in part due to stimulation of intracellular signal JAK2/STAT3 pathway. Additionally, those inspire us to suppose that LPS could produce a more and faster drastic effect in RA progression than do CFA.
CONCLUSION
Conclusively, according to the results of the present investigation, it is clearly obvious that LPS that was never used earlier as a model for RA induction can be a perfect model for experimental induction of RA at least in part through stimulation of JAK2/STAT3 signaling pathway.
